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Background: Bone metastases arise in nearly 70% of patients with advanced breast cancer, but the complex metastatic
process has not been completely clarified yet. RANKL/RANK/OPG pathway modifications and the crosstalk between
metastatic cells and bone have been indicated as potential drivers of the process. Interactions between tumor and
bone cells have been studied in vivo and in vitro, but specific effects of the direct contact between human metastatic
cells and human bone cells on RANKL/RANK/OPG pathway have not been investigated.
Findings: We directly co-cultured bone metastatic human breast cancer cells (BOKL) with osteo-differentiated human
mesenchymal cells (BMSCs) from 3 different donors. BMSCs and BOKL were then enzymatically separated and FACS
sorted. We found a significant increase in the RANKL/OPG ratio as compared to control, which was not observed
in BOKL cultured in medium conditioned by BMSCs, neither in BOKL directly cultured with fibroblasts or medium
conditioned by fibroblasts. Direct co-culture with osteo-differentiated BMSCs caused BOKL aggregation while
proliferation was not affected by co-culture. To more specifically associate RANKL expression to osteogenic
differentiation degree of BMSCs, we determined their osteogenic markers expression and matrix calcification
relative to osteoblasts and fibroblasts.
Conclusions: In conclusion, our co-culture model allowed to demonstrate for the first time that direct contact but not
paracrine interactions between human metastatic breast cancer cells and bone cells has a significant effect on RANKL/
OPG expression in bone metastatic cells. Furthermore, only direct contact with the bone microenvironment induced
BOKL clustering without however significantly influencing their proliferation and migration.
Keywords: Bone metastasis, In vitro co-cultures, Gene expression analyses, RANKL pathway, Heterotypic cell contactsFindings
Introduction
Bone metastases arise in nearly 70% of patients with ad-
vanced breast cancer, indicating bone as a favorable
microenvironment for metastases, which onset dramat-
ically alters physiological bone turnover, leading to bone
lysis. It has been reported [1] that this can be caused by* Correspondence: matteo.moretti@grupposandonato.it
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unless otherwise stated.the up-regulation of RANKL to OPG ratio, causing an in-
creased osteoclastogenesis [2], although the mechanisms
inducing RANKL/OPG modification are not clear [1,3].
Recently, interactions between metastatic cells and
metastatic niche cells have been indicated as potential
drivers of the metastatic process [4]. Thus, to under-
stand the cross-talk between metastatic breast cancer
cells and bone microenvironment, many in vitro co-
culture models have been established [5-10]. The major-
ity of these [5,6] involve human tumor cells cultured
with mouse osteoblasts, but osteoblasts from differentl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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nisms underlying metastasis formation can be diverse
between mouse and human [12]. Moreover, while some
studies reported the culture of human tumor cells in
conditioned medium from human bone cells, highlighting
only soluble factors effects [7,8], only a few works [9,10]
implemented direct contact between human tumor and
bone cells. However, gene expression analyses on individ-
ual cell populations have not always been performed [9].
Our work was thus aimed at investigating, by means of
direct co-culture, the interactions between a line of fluo-
rescently tagged bone metastatic human breast cancer
cells, MDA-MB231-BO-KL (BOKL) and a bone micro-
environment represented by osteo-differentiated primary
human bone marrow stromal cells (BMSCs), in terms of
modifications on RANKL/RANK/OPG expression, cell
proliferation and migration.
Direct contact with bone-like cells induced RANKL/OPG
up-regulation in metastatic cells
To investigate whether specific direct contact between
bone and tumor cells is involved in RANKL/OPG ratio
modifications, we compared gene expression of BOKL
after 3 days of direct co-culture with osteo-differentiated
BMSCs (co-culture BMSCs) with that of BOKL cultured
in conditioned medium from osteo-differentiated BMSCs
(CM BMSCs) and that of BOKL in direct or indirect co-
culture with fibroblasts, non osteogenic cells (co-culture
MRC-5, CM MRC-5). Based on literature data showing
that cell populations with equivalent capacity to form
bone metastasis also share equal expression of genes re-
lated to bone invasion and metastasis [13], we chose to
use a single bone seeking clone [14], with equivalent bone
metastatic potential as compared to other bone seeking
clones [13]. BMSCs were harvested from 3 patients under-
going hip surgery, after informed consent, and were differ-
entiated in osteogenic medium (OM), as described [15].
BOKL and BMSCs after direct co-culture with BMSCs or
MRC-5 were retrieved by enzymatic digestion and sepa-
rated by FACS sorting. To exclude modifications in gene
expression caused by the separation procedure, gene ex-
pression levels were normalized respective to those of
BOKL grown in GM and then subjected to the same
separation procedure (control 1). CM for indirect co-
culture was harvested from the same BMSCs and
MRC-5 used in direct co-cultures and gene expression
of BOKL in CM was normalized respective to BOKL
grown in GM (control 2). All materials and methods are
described in Additional file 1: Materials and methods.
Results of PCR analyses showed a strong and statistically
significant upregulation (13 fold, p < 0.05) of RANKL in
BOKL co-culture BMSCs as compared to control 1 but not
in BOKL CM BMSCs and BOKL CM MRC-5 (Figure 1A,
p < 0.05 and p < 0.01, respectively). A small increase (notstatistically significant) in RANKL was observed in
BOKL co-culture MRC-5 where a significant upregula-
tion of OPG was found (Figure 1A), differently from all
other conditions. Altogether our results show that
RANKL/OPG ratio (a more useful indicator of effect-
ively available RANKL) in BOKL co-culture BMSCs is 7
fold increased (Figure 1B) relative to control, and sig-
nificantly higher (p < 0.01) than all other conditions,
where no increase was found, demonstrating that dir-
ect, specific contact between tumor and bone cells can
modify RANKL/OPG ratio. This suggests that among
other factors hypothesized in the literature [1], hetero-
typic interactions between metastatic and bone cells
can be involved in RANKL/OPG imbalance.
We demonstrated a specific activation of RANKL/
OPG and not a generalized change in gene expression,
since CDH11, known to be highly expressed in bone-
seeking clones [16], and RANKL receptor RANK were
not significantly modified in BOKL after direct or indir-
ect co-cultures (Figure 1A). We also analyzed gene ex-
pression of BMSCs after direct co-culture and we found
that average value of RANKL and osteogenic differenti-
ation markers expression did not significantly differ be-
tween osteo-differentiated BMSCs before and after direct
co-culture. However, 1 out of 3 patients derived osteo-
differentiated BMSCs (patient 2) showed a 4-fold RANKL
up regulation after direct co-culture, due to the high bio-
logical variability of primary human cells (Figure 1C, D).
RANK expression was instead significantly upregulated
in BMSCs after co-culture with tumor cells (Figure 1C,
p < 0.01 as compared to BMSCs before co-culture), dif-
ferently from MRC-5, which showed no expression of
RANK before or after co-culture (data not shown), con-
firming a specific activation of the RANKL/OPG/RANK
pathway caused by the crosstalk between tumor cells and
bone microenvironment.
The separation of metastatic cells from bone-like cells
was based on fluorescent labeling of cells before co-
culture, giving a particular reliability to our results. An-
other study analyzed gene expression of tumor cells in
direct co-culture with BMSCs [10], separating the two
cell populations on the basis of epithelial markers ex-
pression. It is however known that highly aggressive breast
cancer cells in co-culture with BMSCs can undergo
epithelial-to-mesenchymal transition [17], causing a loss
of epithelial markers and consequently affecting cell separ-
ation reliability.
Direct co-culture effects on BOKL aggregation, migration
and proliferation
With the aim to analyze effects of direct contact between
bone-like cells and BOKL on aggregation, migration and
proliferation, time lapse analyses were performed, reveal-
ing an evident BOKL aggregation in direct co-culture with
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Figure 1 Gene expression of BOKL and BMSCs from different patients cultured for 3 days in direct contact. A) Expression of genes
related to RANK/RANKL/OPG pathway and CDH11 in BOKL after direct co-culture with osteo-differentiated BMSCs (BOKL co-culture BMSC) compared
with BOKL cultured in medium conditioned by the same osteo-differentiated BMSCs (BOKL CM BMSC), with BOKL after direct co-culture with
fibroblasts (BOKL co-culture MRC-5) and with BOKL cultured in medium conditioned by the same fibroblasts (BOKL CM MRC-5). *: p < 0.05,
**: p < 0.01 and ***: p < 0.001. Fold changes were calculated respective to control 1 or 2 (expression set to 1, dotted line). Control 1: BOKL
grown in GM and subjected to enzymatic digestion and FACS sorting, used for BOKL from both direct co-cultures, control 2: BOKL grown in
GM, used for BOKL in both CMs. B) RANKL/OPG ratio, for BOKL after direct co-culture with BMSCs and fibroblasts (BOKL co-culture BMSC and
BOKL co-culture MRC-5) and in BOKL cultured in medium conditioned by BMSCs and fibroblasts (BOKL CM BMSC and BOKL CM MRC-5). **: p < 0.01.
C) Gene expression of osteocalcin (OCN), osteopontin (OPN), RUNX-2 and RANK in BMSCs from three different patients (Pt1, Pt2, Pt3) after direct
co-culture with BOKL. Fold changes were calculated respective to the same BMSCs before co-culture (expression value set to 1, dotted line). D) RANKL
expression of BMSCs before (BMSC CTRL) and after direct co-culture (BMSCs co-culture BOKL), relative to three different patients, compared to that of
osteoblasts. Fold changes were calculated respective to fibroblasts (expression set to 1, dotted line). All error bars represent standard deviations of at
least three different experiments.
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http://www.molecular-cancer.com/content/13/1/238osteo-differentiated BMSCs, not noticeable in the other
conditions, as shown in fluorescence images (Figure 2A,
B, C, D). This phenomenon resembled cell filing, already
described in pathological tissues bearing metastases [5].
Interestingly, BOKL clustering did not occur in co-culture
with MRC-5, suggesting that this can represent a specific
effect of the direct contact with bone cells. Cluster num-
ber normalized to total cell number was indeed signifi-
cantly higher in BOKL co-culture BMSCs, as compared
to other conditions (p < 0.001, Figure 2E). We observed
a preferential direction of cell migration in direct co-culture as compared to culture with CM or GM (p < 0.01,
Figure 2F), probably due to cell contact guidance [18] and
not to specific characteristics of cells that composed the
monolayer, being this effect evident also in co-culture with
MRC-5. Figure 2G reports the quantification of BOKL
proliferation in the different conditions, showing no sig-
nificant differences between BOKL co-culture BMSCs and
BOKL CM BMSCs. BOKL grown in 100% CM did not
show a lower degree of proliferation as compared to con-
trol 2, indicating that CM can support BOKL growth. On
the other hand, BOKL in contact with fibroblasts showed
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Figure 2 Cell migration, aggregation and proliferation in different conditions. Fluorescence images of: A) BOKL in direct co-culture with
BMSCs (arrow indicates a cell cluster), B) BOKL cultured in CM BMSCs, C) BOKL in co-culture with MRC-5 and D) BOKL in GM. All the images have
been taken after 3 days of culture. E) Quantification of the cell aggregation, expressed as the average number of clusters normalized per total cell
number. Clusters were defined as groups of at least four cells in contact, as already reported for micrometastasis [20]. ***: p < 0.001, **p < 0.01 vs.
other conditions. F) Quantification of the directionality of the cell movement, expressed as index P. P is defined as A1/A2, where A1 is the distance
between the position of the cell in the last image and that in the first. A2 is the sum of distances travelled by the cell in all the images [21]. Values of
P near 1 indicate a directional movement. **: p < 0.01 vs. other conditions. G) Proliferation of BOKL after 3 days of direct co-culture with BMSCs or
MRC-5 and after 3 days in culture with conditioned medium from BMSCs (CM) or control medium (CTR), ***: p < 0.001. All error bars represent standard
deviations of at least three different experiments.
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http://www.molecular-cancer.com/content/13/1/238a significantly higher (p < 0.001) proliferation, accordingly
to literature results showing how the release of specific
factors (such as interleukin-6) by fibroblasts can increase
the growth of breast cancer cells [19].
Characterization of bone-like microenvironment
To establish a bone-like environment we differentiated
BMSCs for 14 days in osteogenic medium, having previ-
ous surveys and literature data [22] established that it
allowed to achieve adequate osteo-differentiation. How-
ever, considering the time-dependence of differentiationmarkers expression and the different effects reported on
tumor cells co-cultured with variously differentiated bone
cells [6], we determined the osteodifferentiation degree of
BMSCs used in our experiments with reference to both
terminally differentiated osteoblasts and MRC-5. We
characterized BMSCs osteodifferentiation through Alka-
line Phosphatase (ALP) assay, Alizarin red staining and
calcium quantification. Moreover, expression of both early
(RUNX-2) and late osteogenic markers (osteopontin and
osteocalcin) [23], was determined. After 14 days in osteo-
genic medium, BMSCs from all the 3 different donors
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Figure 3 Characterization of the bone-like microenvironment. Characterization of the osteo-differentiation level of BMSCs from three different
patients cultured for 14 days in osteogenic medium (DMEM additioned with 10% FBS, 1% HEPES, 1% pen strep, 15 mM ascorbic acid, 10 mM β −
glycerophosphate, 10 nM dexamethasone, 10nM cholecalciferol). A) Alizarin red staining for the three different BMSCs populations; B) Expression
of typical osteoblastic markers, normalized to MRC-5 expression (set to 1) and also quantified in RNA deriving directly from human bone samples
(osteoblasts). *: p < 0.05, ***: p < 0.001 as compared to osteoblasts expression. All error bars represent standard deviations of at least three
different experiments.
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http://www.molecular-cancer.com/content/13/1/238showed positive Alizarin red staining (Figure 3A), demon-
strating the presence of calcium deposits. Their quantifi-
cation demonstrated significantly higher calcium levels in
BMSCs as compared to MRC-5 (p < 0.001, Additional
file 2: Figure S1A). ALP activity, index of initial osteo-
genic commitment of cells, normalized to total protein
content, was detectable in all the 3 patients at compar-
able levels as shown in Additional file 2: Figure S1B.
Moreover, the expression of osteogenic markers osteo-
pontin, osteocalcin and RUNX-2 was significantly up-
regulated in osteo-differentiated BMSCs as compared to
MRC-5. Osteopontin and osteocalcin expression was signifi-
cantly lower than in primary osteoblasts (p < 0.05) whereas
expression of RUNX-2 was comparable (Figure 3B).
In conclusion, our simple co-culture model allowed to
obtain results otherwise not possible to achieve in
in vivo experiments, whereby it would be impossible to
sort, separate and analyze the cell populations involved
in the metastatic process. In particular, we demonstrated
for the first time that direct but not indirect co-culture
between human tumor cells and primary bone-like cells
induced a significant up-regulation of RANKL/OPG ex-
pression in bone metastatic cells, suggesting an import-
ant role of direct contact in the bone metastatic process.This is in line with the reported clinical expression, de-
termined by immunohistochemistry, of RANKL in hu-
man bone metastases [24,25]. Furthermore, although we
do not yet have a mechanistic explanation, upregulation
of RANKL/OPG ratio and BOKL clustering observed only
in direct co-culture with osteo-differentiated BMSCs and
not in culture with conditioned medium or in direct co-
culture with fibroblasts, further support the hypothesis
that heterotypic cell interactions between tumor cells and
bone cells can have a key role in the establishment of bone
metastases.
Additional files
Additional file 1: Materials and methods. Detailed information about
cell isolation, differentiation and culture, gene expression and time lapse
analyses.
Additional file 2: Figure S1. Confirmation of osteo-differentiation of
BMSCs. A) Quantification of calcium deposits for BMSCs from three different
patients. ***: p < 0.001, compared to fibroblasts. B) Quantification of ALP
activity, normalized to the total protein content. All error bars represent
standard deviations of at least three different experiments.
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